Today: 7 February 2026
Subscribe
Browse Category

Cybersecurity News 14 January 2026 - 7 February 2026

Palo Alto Networks stock snaps back after sharp slide as NextWave overhaul lands before earnings

Palo Alto Networks stock snaps back after sharp slide as NextWave overhaul lands before earnings

Palo Alto Networks shares closed up 2.9% at $159.32 on Friday, recovering part of Thursday’s 7.2% drop. The company announced a revamped NextWave partner program focused on bundled security platforms. Software stocks rebounded with the broader market after heavy losses earlier in the week. Investors await Palo Alto’s Feb. 17 earnings for signs of demand and margins.
7 February 2026
····
Qualys stock slides nearly 13% after Q4 beat as 2026 outlook cools the mood

Qualys stock slides nearly 13% after Q4 beat as 2026 outlook cools the mood

Qualys shares dropped 12.7% to $111.62 Friday after the company forecast 2026 revenue growth of 7% to 8%, below last year’s 10%. The cybersecurity firm reported fourth-quarter revenue of $175.3 million and raised its share buyback program by $200 million. RBC and Truist trimmed price targets. CEO Sumedh Thakar received performance shares, with some withheld for taxes.
6 February 2026
···
Palo Alto Networks stock pops as PANW rolls out NextWave partner reboot into earnings week

Palo Alto Networks stock pops as PANW rolls out NextWave partner reboot into earnings week

Palo Alto Networks shares rose 2.4% to $158.44 Friday, rebounding from a 7.2% drop after the company launched an updated partner program to drive bundled platform sales. Channel Chief Michael Khoury said the overhaul includes new incentives and dropped discount caps. Investors await the Feb. 17 earnings report for signs of demand. Cybersecurity peers Fortinet and CrowdStrike also posted gains.
6 February 2026
··
CrowdStrike stock rebounds as Aramco pact lifts CRWD after bruising software selloff

CrowdStrike stock rebounds as Aramco pact lifts CRWD after bruising software selloff

CrowdStrike shares rose 3.7% to $391.20 Friday, rebounding after a 9.2% drop the previous day amid a broader software sell-off. The company announced a memorandum of understanding with Saudi Aramco to explore cybersecurity projects in the kingdom. Other cybersecurity stocks showed mixed moves. CrowdStrike will report quarterly results on March 3.
6 February 2026
····
Palo Alto Networks stock drops after Chronosphere deal closes, with earnings next in focus

Palo Alto Networks stock drops after Chronosphere deal closes, with earnings next in focus

Palo Alto Networks shares fell 4.8% to $174.85 Thursday after closing its $3.35 billion acquisition of observability firm Chronosphere. The stock edged up to $176.20 in after-hours trading. Investors are watching for Palo Alto’s Feb. 12 earnings report for updates on integration and the deal’s impact.
30 January 2026
······
CrowdStrike stock slips late in session despite Gartner “Customers’ Choice” nod — what CRWD investors watch next

CrowdStrike stock slips late in session despite Gartner “Customers’ Choice” nod — what CRWD investors watch next

CrowdStrike shares fell 1% to $472.04 Wednesday, despite winning Gartner’s “Customers’ Choice” badge for endpoint protection. The drop followed the Fed’s decision to hold rates steady and came as analysts cited valuation concerns. Legal issues linger after last July’s outage, with some lawsuits still active. CrowdStrike’s next earnings report is expected around March 3.
28 January 2026
··
Netskope stock rises as Telefónica Tech rolls out “Security Edge” service in UK, Ireland

Netskope stock rises as Telefónica Tech rolls out “Security Edge” service in UK, Ireland

Netskope shares rose 3.2% to $15.92 Tuesday after Telefónica Tech UK&I launched a managed security service using Netskope’s platform in the UK and Ireland. Trading volume reached 3.6 million shares. The move comes days before Netskope’s Jan. 31 fiscal year-end, with investors watching for subscription growth and partner-driven revenue impact.
27 January 2026
····
IBM stock slides in afternoon trade as investors brace for earnings and fresh security news

IBM stock slides in afternoon trade as investors brace for earnings and fresh security news

IBM shares fell 1.1% to $291.51 Friday, underperforming other tech giants as traders braced for next week’s earnings and 2026 guidance. IBM Consulting announced a new “quantum-safe” security partnership, while analysts highlighted renewed software growth and the pending $11 billion Confluent deal. The company reports Q4 results on Jan. 28.
23 January 2026
···
Palo Alto Networks (PANW) stock slips while cyber peers climb as AI security talk heats up

Palo Alto Networks (PANW) stock slips while cyber peers climb as AI security talk heats up

Palo Alto Networks shares fell 1% to $180.46 Friday, underperforming tech peers after launching new AI-driven security products. Most cybersecurity stocks rose, with Fortinet up over 5%. The company this week announced updates to its Hybrid Mesh Firewall and a new Prisma Browser Connector. Investors await Palo Alto’s next earnings report amid concerns over security spending and growth forecasts.
23 January 2026
···
CrowdStrike stock price: CRWD holds near $454 as China ban chatter and a court win hang over the trade

CrowdStrike stock price: CRWD holds near $454 as China ban chatter and a court win hang over the trade

CrowdStrike shares closed down 0.2% at $453.88, steady after hours. China reportedly ordered firms to stop using some foreign cybersecurity tools, but CrowdStrike said it does not sell in China. A U.S. judge dismissed a shareholder lawsuit over the July 2024 outage, though the complaint may be amended. U.S. markets close Monday for Martin Luther King Jr. Day.
17 January 2026
··
ServiceNow stock drops nearly 3% as security flaw headlines linger ahead of Jan. 28 earnings

ServiceNow stock drops nearly 3% as security flaw headlines linger ahead of Jan. 28 earnings

ServiceNow shares fell 2.9% to $127.31 in after-hours trading Friday, extending a week of declines and leaving the stock 47% below its 52-week high. The drop followed news of a major AI security flaw, “BodySnatcher,” which the company says has been patched. U.S. stocks closed flat ahead of the Martin Luther King Jr. Day holiday. ServiceNow reports earnings Jan. 28.
17 January 2026
···
CrowdStrike stock price today: CRWD steadies after China ban report and outage lawsuit dismissal

CrowdStrike stock price today: CRWD steadies after China ban report and outage lawsuit dismissal

CrowdStrike shares closed up 0.2% at $455.91 Friday after the company said it expects minimal impact from China’s push to replace foreign cybersecurity software. A U.S. judge dismissed a shareholder lawsuit over the 2024 outage, though Delta Air Lines’ suit continues. CEO George Kurtz’s trust filed to potentially sell $9.66 million in shares. Broader market activity remained cautious ahead of the long weekend.
16 January 2026
··
CrowdStrike stock slips after judge tosses outage lawsuit as CRWD pushes deeper into browser security

CrowdStrike stock slips after judge tosses outage lawsuit as CRWD pushes deeper into browser security

CrowdStrike shares fell 1.7% to $459.98 Wednesday after a U.S. judge dismissed a shareholder fraud lawsuit tied to the company’s July 2024 outage. The judge ruled investors failed to show CrowdStrike misled them about software testing. The New York State Common Retirement Fund said it is reviewing the decision. CrowdStrike also announced a deal to acquire Seraphic Security, with closing expected in its first fiscal quarter of 2027.
14 January 2026
··
1 2 3 … 10

Stock Market Today

AstraZeneca stock price: What could move AZN next week as earnings loom

AstraZeneca stock price: What could move AZN next week as earnings loom

7 February 2026
AstraZeneca shares rose Friday, closing at $193.03 in New York, up 3.1%, and 14,104p in London, up 0.9%. The company reports full-year and Q4 2025 results Tuesday, with investors focused on 2026 guidance. The FDA this week issued a complete response letter for a subcutaneous Saphnelo filing, while granting Priority Review to Datroway for breast cancer. AstraZeneca recently shifted its primary U.S. listing to the NYSE.
Go toTop